Secondary hyperparathyroidism (patient information): Difference between revisions

Jump to navigation Jump to search
Line 41: Line 41:
==Diagnosis==
==Diagnosis==
:*Blood tests: Patients with secondary hyperparathyroidism may indicate signs, such as elevated levels of [[parathyroid hormone]] (PTH), a low serum [[calcium]], and an abnormal serum phosphorus. Blood tests can also check renal functions of the patients.   
:*Blood tests: Patients with secondary hyperparathyroidism may indicate signs, such as elevated levels of [[parathyroid hormone]] (PTH), a low serum [[calcium]], and an abnormal serum phosphorus. Blood tests can also check renal functions of the patients.   
:*Bone densitometry: The doctor may arrange a dual x-ray absorptiometry to determine bone density and to reveal bone loss, [[fracture]]s, or bone softening.  
:*[[Bone densitometry]]: The doctor may arrange a dual x-ray absorptiometry to determine bone density and to reveal bone loss, [[fracture]]s, or bone softening.  
:*Imaging tests: Imaging tests such as [[x-ray]]s, [[ultrasound]], [[CT]] or [[MRI]] scans of the kidneys and nuclear imaging may show signs of calcium deposits or a blockage, certain type of [[cancer]].
:*Imaging tests: Imaging tests such as [[x-ray]]s, [[ultrasound]], [[CT]] or [[MRI]] scans of the kidneys and nuclear imaging may show signs of calcium deposits or a blockage, certain type of [[cancer]].



Revision as of 17:59, 20 September 2012

For the WikiDoc page for this topic, click here

Secondary hyperparathyroidism
Thyroid and parathyroid.
ICD-10 E21.1
ICD-9 252.02, 588.81
DiseasesDB 6301
MeSH D006962

WikiDoc Resources for Secondary hyperparathyroidism (patient information)

Articles

Most recent articles on Secondary hyperparathyroidism (patient information)

Most cited articles on Secondary hyperparathyroidism (patient information)

Review articles on Secondary hyperparathyroidism (patient information)

Articles on Secondary hyperparathyroidism (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Secondary hyperparathyroidism (patient information)

Images of Secondary hyperparathyroidism (patient information)

Photos of Secondary hyperparathyroidism (patient information)

Podcasts & MP3s on Secondary hyperparathyroidism (patient information)

Videos on Secondary hyperparathyroidism (patient information)

Evidence Based Medicine

Cochrane Collaboration on Secondary hyperparathyroidism (patient information)

Bandolier on Secondary hyperparathyroidism (patient information)

TRIP on Secondary hyperparathyroidism (patient information)

Clinical Trials

Ongoing Trials on Secondary hyperparathyroidism (patient information) at Clinical Trials.gov

Trial results on Secondary hyperparathyroidism (patient information)

Clinical Trials on Secondary hyperparathyroidism (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Secondary hyperparathyroidism (patient information)

NICE Guidance on Secondary hyperparathyroidism (patient information)

NHS PRODIGY Guidance

FDA on Secondary hyperparathyroidism (patient information)

CDC on Secondary hyperparathyroidism (patient information)

Books

Books on Secondary hyperparathyroidism (patient information)

News

Secondary hyperparathyroidism (patient information) in the news

Be alerted to news on Secondary hyperparathyroidism (patient information)

News trends on Secondary hyperparathyroidism (patient information)

Commentary

Blogs on Secondary hyperparathyroidism (patient information)

Definitions

Definitions of Secondary hyperparathyroidism (patient information)

Patient Resources / Community

Patient resources on Secondary hyperparathyroidism (patient information)

Discussion groups on Secondary hyperparathyroidism (patient information)

Patient Handouts on Secondary hyperparathyroidism (patient information)

Directions to Hospitals Treating Secondary hyperparathyroidism (patient information)

Risk calculators and risk factors for Secondary hyperparathyroidism (patient information)

Healthcare Provider Resources

Symptoms of Secondary hyperparathyroidism (patient information)

Causes & Risk Factors for Secondary hyperparathyroidism (patient information)

Diagnostic studies for Secondary hyperparathyroidism (patient information)

Treatment of Secondary hyperparathyroidism (patient information)

Continuing Medical Education (CME)

CME Programs on Secondary hyperparathyroidism (patient information)

International

Secondary hyperparathyroidism (patient information) en Espanol

Secondary hyperparathyroidism (patient information) en Francais

Business

Secondary hyperparathyroidism (patient information) in the Marketplace

Patents on Secondary hyperparathyroidism (patient information)

Experimental / Informatics

List of terms related to Secondary hyperparathyroidism (patient information)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Jinhui Wu, M.Dd

Overview

Secondary hyperparathyroidism is an endocrine disorder that the parathyroid glands produce too much parathyroid hormone (PTH). The most important cause of secondary hyperparathyroidism is chronic renal failure. Other causes include rickets, malnutrition or malabsorption, and certain types of cancer. Signs and symptoms include symptoms of diseases above, such as weakness, poor growth, bowed limbs and swollen joints in children, bone pain, osteomalacia, osteoporosis, fractures, even symptoms of certain cancer. Blood tests of parathyroid hormone and biochemistry, and imaging tests may help the diagnosis of secondary hyperparathyroidism. Treatments and prognosis of secondary hyperparathyroidism depend on the underlying cause.

What are the symptoms of secondary hyperparathyroidism?

Symptoms of secondary hyperparathyroidism include symptoms of chronic renal failure, malabsorption, rickets and underlying cancer. General symptoms are the following:

Who is at highest risk?

What causes Secondary hyperparathyroidism?

Diagnosis

  • Blood tests: Patients with secondary hyperparathyroidism may indicate signs, such as elevated levels of parathyroid hormone (PTH), a low serum calcium, and an abnormal serum phosphorus. Blood tests can also check renal functions of the patients.
  • Bone densitometry: The doctor may arrange a dual x-ray absorptiometry to determine bone density and to reveal bone loss, fractures, or bone softening.
  • Imaging tests: Imaging tests such as x-rays, ultrasound, CT or MRI scans of the kidneys and nuclear imaging may show signs of calcium deposits or a blockage, certain type of cancer.

When to seek urgent medical care?

Call your health care provider if you have symptoms of secondary hyperparathyroidism , particularly if you are being treated for kidney disease. If you suffer either of the following symptoms, seeking urgent medical care as soon as possible:

Treatment options

Correcting the calcium level and the underlying problem can bring the PTH levels back to normal.

Treatment may involve:

Patients with chronic kidney failure are usually given calcium and vitamin D, and are told to avoid phosphate in their diet. A medication called cinacalcet (Sensipar) may also be recommended. Dialysis, a kidney transplant, or parathyroid surgery may be needed.

Diseases with similar symptoms

Where to find medical care for secondary hyperparathyroidism?

Directions to Hospitals Treating secondary hyperparathyroidism

Prevention of secondary hyperparathyroidism

Early diagnosis and treatment of rickets or vitamin D deficiency may prevent this condition. Proper treatment of kidney failure helps reduce symptoms of secondary hyperparathyroidism.

What to expect (Outook/Prognosis)?

The prognosis of secondary hyperparathyroidism depends on the underlying cause.

Possible complications

Persons with kidney problems may continue to produce too much parathyroid hormone even when their calcium level is back to normal. This is called "tertiary hyperthyroidism." Parathyroid surgery may be needed.

Other complications include:

  • Increased risk of broken bones
  • Renal osteodystrophy (a condition that causes bone pain, weakness, and fractures)

Copyleft Sources

http://www.nlm.nih.gov/medlineplus/ency/article/000318.htm

Template:WH Template:WS